Physician profile
Justin Sheehy
NPI 1528407822
$73,828.50
in general payments reported to CMS, 2019-2025
22 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $52K · 2021: $809 · 2022: $754 · 2023: $785 · 2024: $1,030 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,257.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $38,154.27 | 2019-2020 | |
| Boston Scientific Corporation | $15,533.58 | 2019-2025 | Watchman Access System, Comet, Wolverine Coronary Cutting Balloon |
| Abbott Laboratories | $14,809.40 | 2019-2025 | Triclip, Mitraclip |
| Edwards Lifesciences Corporation | $3,798.58 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $390.27 | 2021-2022 | |
| Abiomed | $235.74 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $128.49 | 2021-2022 | |
| Acist Medical Systems, INC. | $126.78 | 2019 | |
| Philips North America LLC | $90.64 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.77 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $74.20 | 2021 | |
| Terumo Medical Corporation | $68.69 | 2019 | |
| Heartflow, INC. | $57.01 | 2019 | |
| Amgen INC. | $56.32 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $45.65 | 2022-2023 | Verquvo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.84 | 2022-2024 | |
| Asahi Intecc USA, INC. | $40.55 | 2019 | |
| Siemens Medical Solutions USA, INC. | $28.33 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.53 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $16.45 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $13.32 | 2021 | |
| Novo Nordisk INC | $13.09 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Sheehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.